stars 1 stars 2 stars 3

PROPATH UK – Specialists in spatial transcriptomics and proteomics, molecular pathology and histopathology for biopharma R&D. Propath is an award-winning provider of GLP/GCP compliant contract research services in molecular pathology and NanoString gene expression analysis. NanoString gene and protein expression analysis We offer a comprehensive service: from sample preparation to data analysis, all with robust QA and rapid turnaround. SPATIAL PROFILING: using the GeoMx platform – the only solution to spatially resolve highly multiplexed protein and RNA markers; compatible with FFPE and frozen tissue; non destructive to tissue. HIGH PLEX ANALYSIS: using the nCounter platform – multiplex up to 800 RNA/DNA/protein targets in a single sample; optimised for difficult samples types including FFPE, lysates and biofluids Molecular pathology and contract histology We offer a full range of services including: GLP/GCP histopathology, immunohistochemistry and ISH/FISH Biomarker method development and antibody tissue cross-reactivity assessment Digital slide scanning and digital pathology quantitative image analysis. Contact dave.swatman@propath.co.uk to discuss your study or visit our website at: www.propath.co.uk

Propath UK Questions

The Propath UK annual revenue was $8.4 million in 2026.

Dave Swatman is the Commercial Director of Propath UK.

13 people are employed at Propath UK.

The NAICS codes for Propath UK are [541714, 54171, 541, 5417, 54].

The SIC codes for Propath UK are [873, 87].

Top Propath UK Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users